Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cyclic nucleotide-gated channel subunit beta-1 (CNGB1) is a critical pore-forming subunit of the rod photoreceptor CNG channel, which is activated by cyclic nucleotides (cAMP/cGMP) rather than changes in voltage. In the retina, CNGB1 combines with alpha subunits (primarily CNGA1) to form heterotetrameric channels key for phototransduction under low light conditions by regulating Na⁺ and Ca²⁺ influx. CNGB1 also contains a specialized N-terminal glutamic acid-rich protein (GARP) region crucial for channel targeting and structural integrity of rod outer segments. Pathogenic variants or loss of CNGB1 result in rod dysfunction, leading to retinitis pigmentosa and, in some cases, mild olfactory defects. Apart from rods, alternative splice forms participate in olfactory signaling. No direct pharmacological modulators are clinically used; gene-based therapies are being explored in experimental settings.
For future therapies: Restoration of channel function by gene therapy, targeted repair of pathogenic mutations, or molecular modulation of channel gating. CNGB1's physiological mechanism involves ligand gating by cyclic nucleotides (cAMP, cGMP) causing channel opening and permitting cation influx
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cyclic nucleotide-gated channel subunit beta-1 (CNGB1).